Implementation of quality by design and green chemistry principles to validate the stability indicating method on UHPLC for the simultaneous quantification of Glycopyrronium, Fluticasone, Vilanterol in inhaled formulation

The combination of Glycopyrronium, Fluticasone, and Vilanterol is utilized to manage chronic obstructive pulmonary disease (COPD) and mitigate asthma symptoms. Glycopyrronium functions as an anticholinergic compound, Fluticasone serves as a corticosteroid that mitigates inflammation, and Vilanterol...

Full description

Bibliographic Details

Published in:	Green Analytical Chemistry
Main Authors:	Anitha L, Durga Prasad Beda
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Subjects:	Glycopyrronium Vilanterol Fluticasone AQbD Green analytical chemistry UHPLC
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772577424000697